• The New Money
  • Posts
  • Texas Semiconductor Supremacy, Robotaxis Hit Guangzhou, And The At-Home Blood Testing Business

Texas Semiconductor Supremacy, Robotaxis Hit Guangzhou, And The At-Home Blood Testing Business

The markets and trends that matter, made simple. Discover what’s next.

February 22, 2025

Silicon Labs Wins Grant From Texas Semiconductor Innovation Fund

Silicon Labs (NASDAQ: SLAB) has been awarded a $23 million grant from the Texas Semiconductor Innovation Fund to build out a new research and development facility in the state focused on breakthrough semiconductor designs. The Fund is a part of the Texas CHIPS Act which is aiming to turn Texas into one of the most important regions in America for artificial intelligence and machine learning hardware production.

Bringing Robotaxis To The Busy Streets Of Guangzhou

Pony AI (NASDAQ: PONY) officially launched their robotaxis in Guangzhou, China, becoming the first autonomous vehicle company that has ever been allowed to operate in highly popular routes within the city. The Guangzhou launch comes after the highly successful roll out of Pony AI’s robotaxis in Beijing and the start of the company testing autonomous commercial trucking routes in China.

Hims & Hers Is Getting Into The Blood Testing Business

Hims & Hers (NASDAQ: HIMS) announced they have entered into an agreement to acquire at home blood testing startup Trybe Labs. Their at-home blood testing technology allows individuals to easily get accurate data on hormone levels, cholesterol, thyroid function and even prostate health.

The Sprint

The Markets This Week

+42.6% | Pony AI

+14.8% | Crexendo

+10.7% | Wolfspeed

Looking to connect? Reach out and get in touch.

New here? Join our community of 40,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.